Defunct Company
Total Trials
21
As Lead Sponsor
14
As Collaborator
7
Total Enrollment
4,159
NCT00130208
Effect of Sulodexide in Early Diabetic Nephropathy
Phase: Phase 3
Role: Lead Sponsor
Start: Aug 31, 2005
Completion: Feb 29, 2008
NCT00130312
Effect of Sulodexide in Overt Diabetic Nephropathy
Phase: Phase 4
Completion: Mar 31, 2008
NCT00590954
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
Phase: Phase 2
Role: Collaborator
Start: May 31, 2006
Completion: Nov 11, 2019
NCT00431054
Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer
Phase: Phase 1
Start: Feb 28, 2007
Completion: May 31, 2012
NCT00462202
Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
Start: Apr 30, 2007
NCT00648167
A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)
Start: Mar 31, 2008
Completion: Jan 31, 2009
NCT00873457
Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Start: Aug 31, 2009
Completion: Apr 30, 2013
NCT00967993
Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
Phase: N/A
Start: Jan 31, 2010
Completion: May 31, 2010
NCT01074125
A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
Start: May 31, 2010
Completion: Nov 30, 2010
NCT01191255
A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
Start: Oct 31, 2010
Completion: Feb 28, 2013
NCT01554982
A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
Start: Aug 31, 2012
Completion: Aug 31, 2014
NCT01736397
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Start: Nov 30, 2012
Completion: Dec 31, 2013
NCT02128074
A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia
Start: Apr 30, 2014
Completion: Nov 30, 2014
NCT02268994
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
Start: Oct 31, 2014
Completion: Jan 31, 2016
NCT02492620
Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
Start: Mar 31, 2015
Completion: Nov 30, 2017
NCT02661295
A Study of Ferric Citrate to Improve Inflammation and Lipid Levels
Start: Jul 31, 2015
Completion: Mar 15, 2018
NCT03079869
Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients
Start: May 1, 2017
Completion: Sep 14, 2019
NCT03055598
Ferric Citrate in ESRD Pilot Project
Start: May 11, 2017
Completion: Feb 29, 2020
NCT03236246
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Start: Aug 15, 2017
Completion: Sep 27, 2019
NCT04523727
Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease
Start: Jun 16, 2022
Completion: Oct 31, 2026
NCT04649411
Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Start: Jan 31, 2025
Completion: Mar 31, 2027